Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;9(1):33-42.
doi: 10.1016/S2213-2600(20)30417-3. Epub 2020 Oct 12.

Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000-18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database

Affiliations

Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000-18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database

Stefano Barco et al. Lancet Respir Med. 2021 Jan.

Abstract

Background: Pulmonary embolism (PE)-related mortality is decreasing in Europe. However, time trends in the USA and Canada remain uncertain because the most recent analyses of PE-related mortality were published in the early 2000s.

Methods: For this retrospective epidemiological study, we accessed medically certified vital registration data from the WHO Mortality Database (USA and Canada, 2000-17) and the Multiple Cause of Death database produced by the Division of Vital Statistics of the US Centers for Disease Control and Prevention (CDC; US, 2000-18). We investigated contemporary time trends in PE-related mortality in the USA and Canada and the prevalence of conditions contributing to PE-related mortality reported on the death certificates. We also estimated PE-related mortality by age group and sex. A subgroup analysis by race was performed for the USA.

Findings: In the USA, the age-standardised annual mortality rate (PE as the underlying cause) decreased from 6·0 deaths per 100 000 population (95% CI 5·9-6·1) in 2000 to 4·4 deaths per 100 000 population (4·3-4·5) in 2006. Thereafter, it continued to decrease to 4·1 deaths per 100 000 population (4·0-4·2) in women in 2017 and plateaued at 4·5 deaths per 100 000 population (4·4-4·7) in men in 2017. Among adults aged 25-64 years, it increased after 2006. The median age at death from PE decreased from 73 years to 68 years (2000-18). The prevalence of cancer, respiratory diseases, and infections as a contributing cause of PE-related death increased in all age categories from 2000 to 2018. The annual age-standardised PE-related mortality was consistently higher by up to 50% in Black individuals than in White individuals; these rates were approximately 50% higher in White individuals than in those of other races. In Canada, the annual age-standardised mortality rate from PE as the underlying cause of death decreased from 4·7 deaths per 100 000 population (4·4-5·0) in 2000 to 2·6 deaths per 100 000 population (2·4-2·8) in 2017; this decline slowed after 2006 across age groups and sexes.

Interpretation: After 2006, the initially decreasing PE-related mortality rates in North America progressively reached a plateau in Canada, while a rebound increase was observed among young and middle-aged adults in the USA. These findings parallel recent upward trends in mortality from other cardiovascular diseases and might reflect increasing inequalities in the exposure to risk factors and access to health care.

Funding: None.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Trends in PE-related age-standardised mortality in women and men in the USA and Canada, 2000–17 Data from the WHO Mortality Database. Locally weighted scatterplot smoother lines were used to depict the annual PE-related age-standardised mortality rate (number of deaths with PE as the underlying cause per 100 000 population). PE=pulmonary embolism.
Figure 2
Figure 2
Trends in PE-related age-standardised mortality by race and sex in the USA, 2000–18. Data from the Multiple Cause of Death Database. Locally weighted scatterplot smoother) lines for the age-standardised mortality rate (number of deaths per 100 000 population) related to PE listed as the underlying cause of death (A) or in any position of the death certificate (B). PE=pulmonary embolism.
Figure 3
Figure 3
PE-related mortality across age groups and contribution of PE-related mortality to total mortality in the USA and Canada, 2000–17 Data from the WHO Mortality Database. Mortality rate by age group (observed; A) and average annual number of deaths with PE as the underlying cause per 1000 total deaths (proportionate mortality [B]; showed by locally weighted scatterplot smoother lines). PE=pulmonary embolism.
Figure 4
Figure 4
Trends in PE-related age-standardised mortality in the USA, 2000–18 Data from the Multiple Cause of Death Database. Locally weighted scatterplot smoother lines for the age-standardised mortality rate (number of deaths per 100 000 population) related to PE listed as the underlying cause of death or in any position of the death certificate. To account for differences in age distribution within each age group, age-standardised mortality rates were calculated within each class using weights from the European standard population. PE=pulmonary embolism.
Figure 5
Figure 5
Prevalence of conditions listed as the underlying cause of death on death records of patients with PE in the USA, 2000–18 Data from the Multiple Cause of Death Database. Number of deaths by the underlying cause and proportion of cases among those listing PE codes. PE=pulmonary embolism.
Figure 6
Figure 6
Trends in age-standardised mortality according to the underlying cause of death on records listing PE among the causes of death in the USA, 2000–18 Data from the Multiple Cause of Death Database. Locally weighted scatterplot smoother lines for the annual age-standardised pulmonary embolism-related mortality rate (number of deaths per 100 000 population). PE=pulmonary embolism.

Similar articles

Cited by

References

    1. Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circ Res. 2016;118:1340–1347. - PubMed
    1. Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ., 3rd Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143:697–706. - PubMed
    1. Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med. 2011;171:831–837. - PMC - PubMed
    1. Lehnert P, Lange T, Møller CH, Olsen PS, Carlsen J. Acute pulmonary embolism in a national Danish cohort: increasing incidence and decreasing mortality. Thromb Haemost. 2018;118:539–546. - PubMed
    1. Konstantinides SV, Barco S, Lankeit M, Meyer G. Management of pulmonary embolism: an update. J Am Coll Cardiol. 2016;67:976–990. - PubMed

Publication types

MeSH terms